Post-Market Clinical Study Using TRAQ™ for Minimally Invasive Posterior Sacroiliac Joint Fusion
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age21+
SponsorPainTEQ, LLC
About this trial
The purpose of this study is to evaluate the real-world performance, safety and efficacy of the TRAQ System.
Eligibility criteria
Qualifiers
Age and Body Mass Index (BMI)
Adult patients aged ≥ 21 years at screening.
BMI ≤ 40.
Chronic SIJ Related Pain
Disqualifiers
Pain Source Uncertainty
Alternative Primary Spine Pathology
Other Sacroiliac Pathology a. Presence of known sacroiliac joint pathology other than degenerative SIJ dysfunction, including inflammatory sacroiliitis (e.g., ankylosing spondylitis or other HLA associated spondyloarthropathies), tumor, infection, acute fracture, or crystal arthropathy.
Non SIJ Pain Syndromes
Trial design
Treatments tested in this trial
- Bone Allograft
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov